Latest filing published 21 May 2026 for InspireMD, Inc., €5,522.
Shane Thomas Gleason is a declared insider of InspireMD, Inc., with filings sourced from SEC (Form 4). The record holds 29 filings, for trades running from 17 May 2023 to 19 May 2026.
The open-market record consists of 24 sales worth €260k, with no purchase. Besides market trades, the filings include 5 share grants. 2026 to date brings no purchases and 24 sales.
The latest filing, published on 21 May 2026, reports an open-market sale of €5,908 in InspireMD, Inc. Filings reach the SEC (Form 4) feed a median of 17 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations